Different Perineal Preparations Before Vaginal Birth to Maternal/Neonatal Infections and Cost Effectiveness
NCT06880445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320
Last updated 2025-08-15
Summary
The vaginal microbiome plays a crucial role in women's health, primarily composed of beneficial bacteria such as Lactobacillus, which help maintain an acidic environment in the vagina, preventing the growth of pathogens. Research indicates that the vaginal environment during pregnancy is more conducive to the growth of Lactobacillus. Traditionally, perineal disinfection is performed during vaginal delivery; however, studies have shown that excessive use of disinfectants like povidone-iodine may reduce the presence of Lactobacillus in the vagina. Furthermore, not using perineal disinfection does not increase the risk of postpartum infections for mothers and infants, and may even benefit the development of the newborn's microbiome. Considering the medical costs and nursing labor involved, this study aims to compare the effects of different perineal preparation methods on postpartum infection rates and medical costs, with the goal of improving maternal and infant care quality during delivery and reducing healthcare costs.
5、 Method This study employs an experimental research design. After obtaining informed consent from participants, they will be randomly assigned to either the control group or the experimental group using a random number table. The control group will undergo perineal preparation using clean water, while the experimental group will use povidone-iodine for disinfection. The study will document patient demographics, prenatal vital signs, maternal and infant postpartum temperatures, blood test results, and oral bacterial culture outcomes to monitor postpartum infection rates. The REEDA scale will be used to assess perineal wound healing.
6、Expected results: The anticipated results indicate that using clean water for perineal preparation will not increase the risk of postpartum infections for mothers and infants, while also saving medical costs. Additionally, water disinfection may allow newborns to acquire beneficial bacteria such as Lactobacillus from the mother's vagina during delivery, promoting healthy gut microbiome development.
Conditions
- Perineal Infection
- Maternal Infections Affecting Fetus or Newborn
- Cost Effectiveness
Interventions
- PROCEDURE
-
Povidone-Iodine (PVP-I)
The experimental group will use povidone-iodine for disinfection.
- PROCEDURE
-
Water
The control group will undergo perineal preparation using clean water
Sponsors & Collaborators
-
Tzu-Ying Huang
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-30
- Primary Completion
- 2025-06-25
- Completion
- 2025-07-01
Countries
- Taiwan
Study Locations
More Related Trials
-
Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal Suppository
NCT06236893 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)
NCT03769688 ·Status: WITHDRAWN ·Phase: PHASE1
-
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
NCT00706368 ·Status: UNKNOWN ·Phase: NA
-
Impact of Maternity Napkins on the Incidence of Vaginal Infections in the Post-partum Period
NCT05806879 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Two Vaginal Solutions in Preoperative Use
NCT03014778 ·Status: UNKNOWN ·Phase: PHASE4
-
Improving Menstrual and VAginal Health for All
NCT06646185 ·Status: RECRUITING ·Phase: NA
-
The Impact of Vaginal Washing on Cervical Inflammation
NCT06615232 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH
NCT05060029 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Lactobacillus in Adjuvant Treatment of RVVC
NCT04699240 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test
NCT04437940 ·Status: COMPLETED
-
Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
NCT00542074 ·Status: COMPLETED ·Phase: NA
-
Stryphnodendron Adstringens Intimate Soap
NCT06085898 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel
NCT02509403 ·Status: WITHDRAWN ·Phase: PHASE1
-
Clinical Protocol CERN Feasibility Study
NCT06933420 ·Status: RECRUITING ·Phase: NA
-
Transplantation of Vaginal Mikrobiome
NCT04855006 ·Status: COMPLETED ·Phase: NA
-
Rwanda Vaginal Microbiota Restoration Study
NCT02459665 ·Status: COMPLETED ·Phase: NA
-
Light Treatment of Vaginal Infections in Reproductive Age Women
NCT06985433 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT06070454 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis
NCT04489290 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
NCT01020396 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
NCT06450990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308046 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Ecosystem and Network in the United States Study
NCT06472765 ·Status: ENROLLING_BY_INVITATION
-
Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis
NCT02365389 ·Status: COMPLETED ·Phase: PHASE2/PHASE3